Virtual FSGS Focus Group Registration – July 16, 2026
Travere Therapeutics, as part of its sponsorship with ASPN, invites pediatric nephrologists to participate in a virtual closed-door session on July 16, 2026, from 4:00–6:00 pm ET, focused on the evolving FSGS treatment landscape. This interactive discussion will explore current management strategies and gather expert insights on the role of Sparsentan in pediatric patients now that it is available in this population. This is an opportunity to engage with peers, share perspectives, and help shape future educational initiatives and ongoing research efforts in FSGS.
Posted: May 4, 2026